SIIM

Siim Pharmaceuticals (officially SIIM PHARMACEUTICAL PRIVATE LIMITED) is an active pharmaceutical company based in New Delhi, India, incorporated in October 2023. The company specializes in the development, marketing, and distribution of a diverse portfolio of healthcare products, including prescription medicines, antibiotics, and dietary supplements. Its commercial product line features formulations such as Felasi Tablets (Cefixime and Lactobacillus) for bacterial infections, Zufax XL Oral Suspension (Rifaximin) for infectious diarrhea, and Simtone-K Suspension for urinary tract wellness. Additionally, the company offers nutritional and nerve support therapies like Neuropath Injection (Methylcobalamin) and Myllin-S Tablets. Siim Pharmaceuticals operates under WHO, GMP, and ISO certifications, utilizing a PCD (Propaganda Cum Distribution) franchise model to expand its reach across India.